Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 11 Aug 2026 for KLAVIYO, INC, €29.3M.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Summit Partners Growth Equity Fund IX-B, L.P.: trading record in brief
Filings by Summit Partners Growth Equity Fund IX-B, L.P. span 2 companies, the busiest being Klaviyo, Inc. and LifeStance Health Group, Inc. We count 2 filings; the first trade dates from 10 August 2026 and the latest from 11 August 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 11 August 2026, reports a transaction of €29.3M in Klaviyo, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Summit Partners Growth Equity Fund IX-B, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
1,845,131 shares@ US$18.36Series A Common stock, par value $0.001 per shareSEC144:0001634426-26-000005
1,088,162 shares@ US$10.620.28% mcap100.0% of flowCommon StockSEC144:0001634426-26-000003
2 of 2 declarations
